In this Journal for Clinical Studies article, Aman Khera, Barry J. Dussault, and Henry J. Riordan write about regulatory and operational considerations with the recent global interest in developing therapies related to cannabis.
Authors:
Aman Khera, MBA, FTOPRA, FRAPS
VP, Regulatory Science, Strategy and Innovation
